文献速递糖尿病

新诊断1型糖尿病青年纵向血清靶向蛋白质组学证实疾病标志物

Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes affirms markers of disease.
PubMed 文献 · Diabetologia · 2025-02-28

本研究在新诊断1型糖尿病青年中验证既往发现的蛋白质与空腹C肽/葡萄糖比值的关联。采用选择反应监测质谱分析146例患者诊断后1年内560份血清样本,并与272名年龄性别匹配的自身抗体阴性未患病家庭成员比较。结果证实载脂蛋白B-100、载脂蛋白M和谷胱甘肽过氧化物酶3与空腹C肽/葡萄糖比值呈显著负相关,且13种靶蛋白中10种在患者与未患病家庭成员间存在一致差异。

要点

  • 在新诊断1型糖尿病青年中证实载脂蛋白B-100、载脂蛋白M和GPX3与空腹C肽/葡萄糖比值呈显著负相关。
  • 13种靶蛋白中10种在1型糖尿病与未患病家庭成员间存在一致差异,包括GPX3、转甲状腺素蛋白、凝血酶原等。
  • 作者认为这些靶向载脂蛋白与诊断后第一年空腹C肽/葡萄糖比值的关联可能与脂质异常有关。

核心结论

  • 验证结果反映了伴随1型糖尿病的生物学变化图景。
  • 靶向载脂蛋白与诊断后第一年空腹C肽/葡萄糖比值的关联可能与1型糖尿病患者观察到的脂质异常有关,并重申载脂蛋白与疾病相关变化之间的联系。
  • 需要进一步研究探索这些靶点的临床价值与相关性。

研究设计与样本

  • 对参与INNODIA研究的新诊断1型糖尿病患者纵向血清样本进行选择反应监测质谱分析。
  • 新诊断组为18岁以下1型糖尿病患者146例,诊断后6周内及诊断后3、6、12个月采集血清,共560份样本。
  • 对照组为年龄和性别匹配的自身抗体阴性未患病家庭成员272名,进行横断面选择反应监测质谱测量。

主要发现

  • 在新诊断个体中证实空腹C肽/葡萄糖比值与载脂蛋白B-100、载脂蛋白M和谷胱甘肽过氧化物酶3(GPX3)肽段之间存在显著(p<0.05)负相关。
  • 观察到1型糖尿病个体与未患病家庭成员之间13种靶蛋白中有10种蛋白水平存在一致差异。
  • 存在一致差异的蛋白包括GPX3、转甲状腺素蛋白、凝血酶原、载脂蛋白C1和afamin。

关键数值与推荐

  • 空腹C肽/葡萄糖比值与载脂蛋白B-100、载脂蛋白M和GPX3肽段的负相关具有统计学显著性(p<0.05)。
  • 13种靶向蛋白中10种在1型糖尿病与未患病家庭成员间显示一致差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要进一步研究探索这些靶点的临床价值与相关性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: While investigating markers for declining beta cell function in type 1 diabetes, we previously demonstrated 11 statistically significant protein associations with fasting C-peptide/glucose ratios in longitudinal serum samples from newly diagnosed (ND) individuals (n=86; 228 samples in total) participating in the INNODIA (Innovative approaches to understanding and arresting type 1 diabetes) study. Furthermore, comparison with protein measurements from age- and sex-matched autoantibody-negative unaffected family members (UFMs, n=194) revealed differences in the serum levels of 13 target proteins. To further evaluate these findings, we analysed longitudinal serum drawn during the first year after diagnosis from a new group of ND individuals subsequently enrolled in the study, together with samples from additional UFMs. METHODS: To validate the previously reported statistically significant protein associations with type 1 diabetes progression, selected reaction monitoring (SRM) MS analyses were carried out. Sera from individuals diagnosed with type 1 diabetes under the age of 18 years (n=146) were collected within 6 weeks of diagnosis and at 3, 6 and 12 months after diagnosis (560 samples in total). The resulting SRM data were compared with fasting C-peptide/glucose measurements, which were used as a proxy for beta cell function. The protein data were further compared with cross-sectional SRM measurements from age- and sex-matched UFMs (n=272). RESULTS: Our results confirmed the presence of significant (p<0.05) inverse associations between fasting C-peptide/glucose ratios and peptides from apolipoprotein B-100, apolipoprotein M and glutathione peroxidase 3 (GPX3) in ND individuals. Additionally, we observed consistent differences in the levels of ten of the 13 targeted proteins between individuals with type 1 diabetes and UFMs. These proteins included GPX3, transthyretin, prothrombin, apolipoprotein C1 and afamin. CONCLUSIONS/INTERPRETATION: The validated results reflect the landscape of biological changes accompanying type 1 diabetes. For example, the association of the targeted apolipoproteins with fasting C-peptide/glucose ratios in the first year after diagnosis is likely to relate to lipid abnormalities observed in individuals with type 1 diabetes, and reiterates the connection of apolipoproteins with the underlying changes accompanying the disease. Further research is needed to explore the clinical value and relevance of these targets.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Moulder R, Hirvonen MK, Välikangas T, et al. Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes affirms markers of disease. Diabetologia. 2025. PMID: 40019499. doi:10.1007/s00125-025-06394-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。